 |  |  |
|
|
 | Removal of Contaminating DNA in Sensitive qPCR and RT-qPCR Applications Morton Elde, ArcticZymes, speaking at Genomics Research Asia 2012 |
 | The Use of -omic Technologies for Biomarker Development Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012 |
qPCR Assay Trends 2013
HTStec
HTStec's qPCR Assay Trends 2013 report was published on 15 April 2013. This 63 page market report summarizes the results of HTStec's 3rd industry-wide global web-based benchmarking survey on real-time quantitative PCR (qPCR) assays and instruments carried out in March 2013.
Benchtop Automation Trends 2013
HTStec
This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on small-scale or benchtop automation carried out in January 2013.
Companion Diagnostics and Personalized Medicine
Select Biosciences Ltd
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace. Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine.
Molecular Diagnostics: Market Landscape
Datamonitor plc
This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests that are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic market over 2010-16 provided.
Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future
GlobalData
GlobalData’s viewpoint, “Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future” provides key insights on the market. The viewpoint provides analysis and future outlook of new technologies and trends on the In-Vitro Diagnostics industry. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
GlobalData
The report provides market landscape, competitive landscape and market trends information on the IVD market in emerging countries. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020)
MarketsandMarkets
This Biomarkers Market research report categorizes on the basis of discovery technologies and application market across major indications; forecasting revenues and analyzing trends.
Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
Koncept Analytics
The global IVD market has been experiencing rapid growth, inspite of the economic recession. There has been growing awareness about health and prevention of diseases among the people, which is expected to further boost the industry’s performance in the coming years.
Molecular Diagnostics Market Report: 2011 Edition
Koncept Analytics
Currently, molecular diagnostics represent a small share in the in-vitro diagnostics market, but it offers immense opportunities for growth in future and therefore, is likely to drive the in-vitro diagnostics market in the foreseeable future.
Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015
Axis Research Mind
The report reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
HTStec
HTStec's qPCR Assay Trends 2013 report was published on 15 April 2013. This 63 page market report summarizes the results of HTStec's 3rd industry-wide global web-based benchmarking survey on real-time quantitative PCR (qPCR) assays and instruments carried out in March 2013.
Benchtop Automation Trends 2013
HTStec
This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on small-scale or benchtop automation carried out in January 2013.
Companion Diagnostics and Personalized Medicine
Select Biosciences Ltd
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace. Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine.
Molecular Diagnostics: Market Landscape
Datamonitor plc
This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests that are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic market over 2010-16 provided.
Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future
GlobalData
GlobalData’s viewpoint, “Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future” provides key insights on the market. The viewpoint provides analysis and future outlook of new technologies and trends on the In-Vitro Diagnostics industry. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
GlobalData
The report provides market landscape, competitive landscape and market trends information on the IVD market in emerging countries. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020)
MarketsandMarkets
This Biomarkers Market research report categorizes on the basis of discovery technologies and application market across major indications; forecasting revenues and analyzing trends.
Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
Koncept Analytics
The global IVD market has been experiencing rapid growth, inspite of the economic recession. There has been growing awareness about health and prevention of diseases among the people, which is expected to further boost the industry’s performance in the coming years.
Molecular Diagnostics Market Report: 2011 Edition
Koncept Analytics
Currently, molecular diagnostics represent a small share in the in-vitro diagnostics market, but it offers immense opportunities for growth in future and therefore, is likely to drive the in-vitro diagnostics market in the foreseeable future.
Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015
Axis Research Mind
The report reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
NIH Researchers Conduct First Genomic Survey of Human Skin Fungal Diversity
Location on the body surface determines fungal composition with the greatest diversity on feet.
App Helps Doctors, Students Learn to Diagnose Neurological Symptoms and Disease
The new app that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
Flu in Pregnancy May Quadruple Child’s Risk for Bipolar Disorder
NIH-funded study adds to evidence of overlap with Schizophrenia.
A Cautionary Tale on Genome-Sequencing Diagnostics for Rare Diseases
Studies in several children have raising new questions about inheritance, genomic sequencing, and diagnostic.
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Rapid development of MS-based proteomic techniques in the last decade that has immensely helped researchers in candidate biomarker discovery.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Genetic Test Helps Predict Risk of Prostate Cancer Recurrence
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
New Lung Cancer Guidelines Recommends Offering Screening to High-Risk Individuals
Advances in treatment have major impact on short- and long-term outcomes.
Genomic Analysis of Endometrial Tumors
Genomic classification of endometrial tumors could help guide treatment strategies, according to a new analysis.
Diagnostic Errors More Common, Costly and Harmful Than Treatment Mistakes
In reviewing 25 years of U.S. malpractice claim payouts, researchers found that diagnostic errors accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Location on the body surface determines fungal composition with the greatest diversity on feet.
App Helps Doctors, Students Learn to Diagnose Neurological Symptoms and Disease
The new app that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
Flu in Pregnancy May Quadruple Child’s Risk for Bipolar Disorder
NIH-funded study adds to evidence of overlap with Schizophrenia.
A Cautionary Tale on Genome-Sequencing Diagnostics for Rare Diseases
Studies in several children have raising new questions about inheritance, genomic sequencing, and diagnostic.
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Rapid development of MS-based proteomic techniques in the last decade that has immensely helped researchers in candidate biomarker discovery.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Genetic Test Helps Predict Risk of Prostate Cancer Recurrence
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
New Lung Cancer Guidelines Recommends Offering Screening to High-Risk Individuals
Advances in treatment have major impact on short- and long-term outcomes.
Genomic Analysis of Endometrial Tumors
Genomic classification of endometrial tumors could help guide treatment strategies, according to a new analysis.
Diagnostic Errors More Common, Costly and Harmful Than Treatment Mistakes
In reviewing 25 years of U.S. malpractice claim payouts, researchers found that diagnostic errors accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Corgenix Announces Diagnostic Development Agreement with Lilly
Companies to focus on potential companion diagnostic opportunity.
Mayo Clinic Forms Joint Venture with Cancer Genetics
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
AB SCIEX launches the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
New ‘Agfa HealthCare Saudi Arabia Company Ltd’ Eyes Local Key Growth Market
Increased presence in KSA to support company’s customers with leading solutions and new technology.
Johns Hopkins Offers Latest Diagnostic Technology: 3-D Mammograms
New screening and diagnostic tool designed for early detection of breast cancer.
GE Scientists in Technology “Relay Race” Against Cancer
GE technologies being developed to impact every stage of cancer patient care from screening to treatment and monitoring.
Vermillion Announces Closing of Equity Financing
Company to increase the number of directors of the Company from six to eight persons.
Vermillion Supports First World Ovarian Cancer Day
Vermillion offers women new hope with OVA1, a FDA-cleared test designed to aid in the prediction of malignancy prior to surgery on an ovarian mass.
Vermillion Reports First Quarter 2013 Results
Building upon early success of OVA1, recent funding sets stage for 2013-2015 strategic plan.
SYGNIS Licenses Amplification Buffer to QIAGEN
This is the second agreement with QIAGEN within 9 months.
Companies to focus on potential companion diagnostic opportunity.
Mayo Clinic Forms Joint Venture with Cancer Genetics
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
AB SCIEX launches the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
New ‘Agfa HealthCare Saudi Arabia Company Ltd’ Eyes Local Key Growth Market
Increased presence in KSA to support company’s customers with leading solutions and new technology.
Johns Hopkins Offers Latest Diagnostic Technology: 3-D Mammograms
New screening and diagnostic tool designed for early detection of breast cancer.
GE Scientists in Technology “Relay Race” Against Cancer
GE technologies being developed to impact every stage of cancer patient care from screening to treatment and monitoring.
Vermillion Announces Closing of Equity Financing
Company to increase the number of directors of the Company from six to eight persons.
Vermillion Supports First World Ovarian Cancer Day
Vermillion offers women new hope with OVA1, a FDA-cleared test designed to aid in the prediction of malignancy prior to surgery on an ovarian mass.
Vermillion Reports First Quarter 2013 Results
Building upon early success of OVA1, recent funding sets stage for 2013-2015 strategic plan.
SYGNIS Licenses Amplification Buffer to QIAGEN
This is the second agreement with QIAGEN within 9 months.
 | ||||||||||||||||
|
Evaluation of 2012 Bowel Cancer Awareness and Early Diagnosis Campaign at a District General Hospital
Brighton and Sussex University Hospitals
Following the regional Be Clear on Cancer campaign, the Department of Health launched a national bowel cancer awareness campaign from 30 January 2012. The campaign ran until the end of March.
FDG PET/CT Utility in Gynecologic Malignancies: A comprehensive review of anatomy, pathways of metastatic spread and scan findings
Emory University Hospital
Our objective was to review the five major gynaecologic cancers (cervical, ovarian, uterine, vaginal, and vulvar) and demonstrate the role of FDG PET/CT in diagnosis, surveillance, FIGO staging and treatment strategy.
Saliva’s Diagnostic Potential
Postgraduate Institute of Dental Sciences
Advantages and disadvantages of using saliva as a diagnostic source of information.
A Systematic Review of Lifestyle Modification in Adults with Non-Alcoholic Fatty Liver Disease
Newcastle University
This study reviews the causes of non-alcoholic fatty liver disease and the associated risk factor for type 2 diabetes and cardiovascular disease.
Rapid PCR for Integration in Sample-to-answer Analysis Platforms
Institut fuer Mikrotechnik Mainz
This poster describes how molecular testing at the point-of-care can increase time to results and yield rather specific information, concentrating on PCR on a chip layout which proves to be fast and robust.
Identification of novel autoantigensin patients with liver autoimmune diseases by Protein MicroArray
1Fondazione INGM, Istituto Nazionale Genetica Molecolare, Milan; 2Fondazione IRCCS Ospedale Maggiore Policlinico, Milano; 3Policlinico Sant’Orsola, Bologna; 4Azienda Ospedaliera Universitaria Pisana,
The characterization of autoimmune disease-specific biomarkers are of primary importance for the development of diagnostic tools and the comprehension of pathogenetic mechanisms leading to autoimmunity. To this aim a protein microarray was employed to analyze serum samples from patients with autoimmune hepatitis (e.g. AIH & PBC) and of healthy as controls. A panel of autoantigens able to discriminate among the groups of patients was identified for potential use as biomarkers.
MicroRNA expression in normal and malignant prostate tissues
University of Skövde
In this study the aim was to identify a miRNA expression signature that could be used to separate between normal and malignant prostate tissues. Nine miRNAs were found to be differentially expressed and they could be used to separate between the normal and malignant tissues. A cross-validation procedure confirmed the generality of this expression signature, showing an accuracy of 85%.
Point-of-Care Diagnostics for Sexually Transmitted Infections
Brunel University
This poster introduces the recently enlarged DoCLab research group at Brunel University, London. This large multidisciplinary group brings together electronic, mechanical and computer engineers with molecular biologists, biochemists and clinical collaborators to develop fully integrated, multiplex Point-Of-Care-Tests (POCT) for the self- diagnosis of infectious diseases.
Optical Microchip Sensors for Multiplexed Detection of Biological Pathogens
Stratophase
SpectroSens, a multi-channel optical microchip sensor system suitable for rapid, label-free multiplexed detection of a wide range of bio-hazardous agents is presented. Optical chips containing multiple high-precision planar Bragg gratings are exploited as low-cost, robust refractive index sensors.
SuNS microarray as novel biosensor for clinical diagnostics.
Molecular Stamping
We here present an innovative microarray platform which aims to produce an higher standard of clinical microarray technology. The fabrication approach, involving a novel printing technology (Supramolecular Nano-Stamping) to reduce the production costs of the chips, together with a peculiar probe design, aiming to improve the assay sensitivity and workflow, intend to make the SuNS microarrays well poised to become an important element in the clinical diagnostics market.
Brighton and Sussex University Hospitals
Following the regional Be Clear on Cancer campaign, the Department of Health launched a national bowel cancer awareness campaign from 30 January 2012. The campaign ran until the end of March.
FDG PET/CT Utility in Gynecologic Malignancies: A comprehensive review of anatomy, pathways of metastatic spread and scan findings
Emory University Hospital
Our objective was to review the five major gynaecologic cancers (cervical, ovarian, uterine, vaginal, and vulvar) and demonstrate the role of FDG PET/CT in diagnosis, surveillance, FIGO staging and treatment strategy.
Saliva’s Diagnostic Potential
Postgraduate Institute of Dental Sciences
Advantages and disadvantages of using saliva as a diagnostic source of information.
A Systematic Review of Lifestyle Modification in Adults with Non-Alcoholic Fatty Liver Disease
Newcastle University
This study reviews the causes of non-alcoholic fatty liver disease and the associated risk factor for type 2 diabetes and cardiovascular disease.
Rapid PCR for Integration in Sample-to-answer Analysis Platforms
Institut fuer Mikrotechnik Mainz
This poster describes how molecular testing at the point-of-care can increase time to results and yield rather specific information, concentrating on PCR on a chip layout which proves to be fast and robust.
Identification of novel autoantigensin patients with liver autoimmune diseases by Protein MicroArray
1Fondazione INGM, Istituto Nazionale Genetica Molecolare, Milan; 2Fondazione IRCCS Ospedale Maggiore Policlinico, Milano; 3Policlinico Sant’Orsola, Bologna; 4Azienda Ospedaliera Universitaria Pisana,
The characterization of autoimmune disease-specific biomarkers are of primary importance for the development of diagnostic tools and the comprehension of pathogenetic mechanisms leading to autoimmunity. To this aim a protein microarray was employed to analyze serum samples from patients with autoimmune hepatitis (e.g. AIH & PBC) and of healthy as controls. A panel of autoantigens able to discriminate among the groups of patients was identified for potential use as biomarkers.
MicroRNA expression in normal and malignant prostate tissues
University of Skövde
In this study the aim was to identify a miRNA expression signature that could be used to separate between normal and malignant prostate tissues. Nine miRNAs were found to be differentially expressed and they could be used to separate between the normal and malignant tissues. A cross-validation procedure confirmed the generality of this expression signature, showing an accuracy of 85%.
Point-of-Care Diagnostics for Sexually Transmitted Infections
Brunel University
This poster introduces the recently enlarged DoCLab research group at Brunel University, London. This large multidisciplinary group brings together electronic, mechanical and computer engineers with molecular biologists, biochemists and clinical collaborators to develop fully integrated, multiplex Point-Of-Care-Tests (POCT) for the self- diagnosis of infectious diseases.
Optical Microchip Sensors for Multiplexed Detection of Biological Pathogens
Stratophase
SpectroSens, a multi-channel optical microchip sensor system suitable for rapid, label-free multiplexed detection of a wide range of bio-hazardous agents is presented. Optical chips containing multiple high-precision planar Bragg gratings are exploited as low-cost, robust refractive index sensors.
SuNS microarray as novel biosensor for clinical diagnostics.
Molecular Stamping
We here present an innovative microarray platform which aims to produce an higher standard of clinical microarray technology. The fabrication approach, involving a novel printing technology (Supramolecular Nano-Stamping) to reduce the production costs of the chips, together with a peculiar probe design, aiming to improve the assay sensitivity and workflow, intend to make the SuNS microarrays well poised to become an important element in the clinical diagnostics market.
Purification of Genomic DNA from Saliva Using Oragene® Discover Collection Kits and the Akonni TruTip® Extraction System on the Hamilton Microlab® STAR Liquid Handling Workstation
Hamilton
In the following studies, we have demonstrated the high precision of the automated TruTip extraction technology in processing genomic DNA from low-volume saliva samples and its advantage over competitors.
Automated Liquid-liquid Extraction of 25-Hydroxy Vitamin D from Serum and Preparation for LC/MC Analysis Using the Hamilton Robotics Microlab STARlet Workstation
Hamilton
This application note demonstrates the automation capabilities of Hamilton Robotics’ Microlab STARlet and how it can be used to prepare clinical serum samples for Vitamin D analysis quickly, reliably and cost effectively.
Recombinase Polymerase Amplification
TwistDx
This application note explains the advantages of RPA and how it simplifies the engineering challenges for point-of-care diagnostics.
Quantitative Determination of Total Bile Acids with a Thermo Scientific Varioskan Flash Multimode Reader Using a Kinetic Enzyme Cycling Assay
Thermo Fisher Scientific
Serum total bile acids (TBA) level is a long-established and accepted indicator of liver diseases. This application note presents a simple photometric measurement of serum TBA.
Pipetting performance of Thermo Scientific Finnpipette F2 in combination with Thermo Scientific Finntip Flex
Thermo Fisher Scientific
The Finnpipette® F2 product family has been designed by taking into account the demands of today´s laboratory work and the require¬ments of the end users. It offers superior comfort, performance, reliability and repeatability in one of the lightest pipettes available.
Turbidometric Growth Curve Measurements and Liquid Evaporation Studies with a Microplate Photometer
Thermo Fisher Scientific
The turbidity of a liquid sample is traditionally measured either with a nephelometer or a photometer. The measure of turbidity (also called optical density, OD) refers to the scattering of light from the particles of the measured sample. When measuring turbidity of a bacterial culture, the amount of scattered light is directly proportional to the number of bacterial cells in the sample.
High Yield and Quality with Thermo Scientific Microtiter Deep Well 96 plates in KingFisher Flex Process
Thermo Fisher Scientific
The Thermo Scientific KingFisher Flex magnetic particle processor is specifically designed to automate the time-consuming sample preparation of proteins, nucleic acids and cells in 96-well plate formats.
Isolation and Purification of Genomic DNA and Viral RNA from Clinical Samples with Thermo Scientific KingFisher Flex
Thermo Fisher Scientific
The purification of DNA and RNA from clinical samples requires rapid and reliable processing of large quantities of samples. Automated purification of nucleic acids, proteins and cells with Thermo Scientific KingFisher Flex is a reproducible and high quality method, which produces excellent material for further analyses.
Ergonomics and Usability Study of Thermo Scientific Finnpipette F1 and F2 Pipettes
Thermo Fisher Scientific
The objective of the study was to evaluate the ergonomics and usability of six manual, singlechannel pipettes. This was done by measuring the load and strain symptoms exhibited by workers’ muscles and joints, and evaluating the usability features of pipettes in a simulated work situation.
Antimicrobial Properties of Thermo Scientific Finnpipette F1 Compared to Traditional Pipettes
Thermo Fisher Scientific
In this application note the antimicrobial properties of the Thermo Scientific Finnpipette F1 were compared to traditional pipettes without antimicrobial treatment. The experiments were performed by an independent laboratory (Institut für Biotechnische Forschung und Entwicklung Graf GmbH, Kirkel-Limbach, Germany).
Hamilton
In the following studies, we have demonstrated the high precision of the automated TruTip extraction technology in processing genomic DNA from low-volume saliva samples and its advantage over competitors.
Automated Liquid-liquid Extraction of 25-Hydroxy Vitamin D from Serum and Preparation for LC/MC Analysis Using the Hamilton Robotics Microlab STARlet Workstation
Hamilton
This application note demonstrates the automation capabilities of Hamilton Robotics’ Microlab STARlet and how it can be used to prepare clinical serum samples for Vitamin D analysis quickly, reliably and cost effectively.
Recombinase Polymerase Amplification
TwistDx
This application note explains the advantages of RPA and how it simplifies the engineering challenges for point-of-care diagnostics.
Quantitative Determination of Total Bile Acids with a Thermo Scientific Varioskan Flash Multimode Reader Using a Kinetic Enzyme Cycling Assay
Thermo Fisher Scientific
Serum total bile acids (TBA) level is a long-established and accepted indicator of liver diseases. This application note presents a simple photometric measurement of serum TBA.
Pipetting performance of Thermo Scientific Finnpipette F2 in combination with Thermo Scientific Finntip Flex
Thermo Fisher Scientific
The Finnpipette® F2 product family has been designed by taking into account the demands of today´s laboratory work and the require¬ments of the end users. It offers superior comfort, performance, reliability and repeatability in one of the lightest pipettes available.
Turbidometric Growth Curve Measurements and Liquid Evaporation Studies with a Microplate Photometer
Thermo Fisher Scientific
The turbidity of a liquid sample is traditionally measured either with a nephelometer or a photometer. The measure of turbidity (also called optical density, OD) refers to the scattering of light from the particles of the measured sample. When measuring turbidity of a bacterial culture, the amount of scattered light is directly proportional to the number of bacterial cells in the sample.
High Yield and Quality with Thermo Scientific Microtiter Deep Well 96 plates in KingFisher Flex Process
Thermo Fisher Scientific
The Thermo Scientific KingFisher Flex magnetic particle processor is specifically designed to automate the time-consuming sample preparation of proteins, nucleic acids and cells in 96-well plate formats.
Isolation and Purification of Genomic DNA and Viral RNA from Clinical Samples with Thermo Scientific KingFisher Flex
Thermo Fisher Scientific
The purification of DNA and RNA from clinical samples requires rapid and reliable processing of large quantities of samples. Automated purification of nucleic acids, proteins and cells with Thermo Scientific KingFisher Flex is a reproducible and high quality method, which produces excellent material for further analyses.
Ergonomics and Usability Study of Thermo Scientific Finnpipette F1 and F2 Pipettes
Thermo Fisher Scientific
The objective of the study was to evaluate the ergonomics and usability of six manual, singlechannel pipettes. This was done by measuring the load and strain symptoms exhibited by workers’ muscles and joints, and evaluating the usability features of pipettes in a simulated work situation.
Antimicrobial Properties of Thermo Scientific Finnpipette F1 Compared to Traditional Pipettes
Thermo Fisher Scientific
In this application note the antimicrobial properties of the Thermo Scientific Finnpipette F1 were compared to traditional pipettes without antimicrobial treatment. The experiments were performed by an independent laboratory (Institut für Biotechnische Forschung und Entwicklung Graf GmbH, Kirkel-Limbach, Germany).
